戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Behcet disease (BD) is a systemic vasculitis with a broa
2                                              Behcet disease can manifest as a purely mucocutaneous di
3                                              Behcet disease is a chronic, relapsing-remitting autoinf
4                                              Behcet disease was associated with higher odds of comple
5                                              Behcet patients with localized RNFL defects were invited
6                                              Behcet syndrome is a systemic vasculitis with an unknown
7                                              Behcet syndrome occurs most commonly along the ancient s
8                                              Behcet's disease (BD) is a chronic, relapsing, systemic
9                                              Behcet's disease (BD) is a multi-system inflammatory dis
10                                              Behcet's disease (BD) is a multi-systemic inflammatory d
11                                              Behcet's disease (BD) is a multisystem disease of unknow
12                                              Behcet's disease (BD) is a multisystem disorder of unkno
13                                              Behcet's disease (BD) is a multisystem immune-mediated i
14                                              Behcet's disease (BD) is a multisystem relapsing inflamm
15                                              Behcet's disease (BD) is a rare, multisystem inflammator
16                                              Behcet's Disease (BD) is diagnosed as continuing systema
17                                              Behcet's disease (BD) is reportedly associated with poly
18                                              Behcet's disease (BD) manifests as an autoimmune disorde
19                                              Behcet's disease (BD) pathogenesis involves severe outco
20                                              Behcet's disease is a genetically complex disease of unk
21                                              Behcet's disease is a multisystem inflammatory disorder
22                                              Behcet's disease is an inflammatory disease characterize
23                                              Behcet's disease is generally considered to be a multifa
24                                              Behcet's disease runs a chronic course, with unpredictab
25                                              Behcet's disease typically arises in young adults, altho
26                                              Behcet-associated uveitis predominantly affects young me
27                    We studied a total of 676 Behcet's disease patients and 1,096 controls.
28 E are juvenile idiopathic arthritis (n = 9), Behcet disease (n = 7), birdshot retinochoroidopathy (n
29 the genetic association between HLA-B*51 and Behcet's disease and exploring additional susceptibility
30 95% confidence interval [CI], 0.19-0.74) and Behcet's disease (aHR, 0.10; 95% CI, 0.01-0.85) were ass
31 iant cell arteritis, Takayasu arteritis, and Behcet's disease.
32 between an HLA class I antigen, HLA-B51, and Behcet's disease has long been known.
33 matosus (SLE) in subjects from Colombia; and Behcet's disease (BD) in subjects from Turkey.
34 s disease, systemic lupus erythematosus, and Behcet's disease.
35 sic part of familial Mediterranean fever and Behcet's disease management.
36  patients, pars planitis in 16 patients, and Behcet's disease in 13 patients.
37 ng recurrent aphthous stomatitis, PFAPA, and Behcet's disease, placing these disorders on a common sp
38 venile idiopathic arthritis, sarcoidosis and Behcet's disease.
39 uding psoriasis, ankylosing spondylitis, and Behcet disease.
40 enic pathways in the spondyloarthritides and Behcet's disease.
41  angiitis of the central nervous system, and Behcet disease, and the clinical and radiologic features
42 ed the genetic association between UBAC2 and Behcet's disease in 3 independent sets of patients and c
43 aliva from patients with aphthous ulcers and Behcet disease prone to oral ulcers failed to induce NET
44 ssel vasculitis, large-vessel vasculitis and Behcet syndrome, are frequently complicated by arterial
45 ly genes with Vogt-Koyanagi-Harada (VKH) and Behcet's disease (BD) in Han Chinese.
46 subset of autoinflammatory diseases, such as Behcet disease, can be caused by rare monogenic variants
47              The genetic association between Behcet's disease and UBAC2 was established, replicated,
48 pothetical patients with uveitic conditions (Behcet disease, birdshot retinochoroiditis, and intermed
49 eitis, and finally, somewhat controversially Behcet's disease.
50 ith KIR3DS1 increased the risk of developing Behcet disease (KIR3DL1(LOW)/KIR3DS1: p = 0.0004, Pc = 0
51 NCA)-associated vasculitis, Crohn's disease, Behcet's disease, eosinophilic granulomatosis with polya
52 ssociated with the autoinflammatory disorder Behcet's disease (BD) in epistasis with HLA-B*51, which
53            We propose naming these disorders Behcet's spectrum disorders to highlight their relations
54 wo other oropharyngeal ulcerative disorders, Behcet's disease and recurrent aphthous stomatitis.
55 current aphthous stomatitis on the mild end, Behcet's disease on the severe end, and PFAPA intermedia
56                             The criteria for Behcet disease uveitis had a low misclassification rate
57                             Key criteria for Behcet disease uveitis were a diagnosis of Behcet diseas
58       Most published diagnostic criteria for Behcet's disease include the classic triad of orogenital
59 d the International Study Group criteria for Behcet's disease.
60 ease using the International Study Group for Behcet Disease criteria and a compatible uveitis, includ
61 ntification of other susceptibility loci for Behcet's disease in multicase families.
62      To discover new susceptibility loci for Behcet's disease, we performed a genome-wide association
63 fied 5 novel genetic susceptibility loci for Behcet's disease.
64 y of alternate, less invasive procedures for Behcet patients.
65              The misclassification rates for Behcet disease uveitis were 0.6% in the training set and
66  II HLA associations for PFAPA distinct from Behcet's disease and recurrent aphthous stomatitis.
67  Takayasu arteritis, Wegener granulomatosis, Behcet syndrome, and transplant arteriosclerosis.
68                                           In Behcet uveitis, localized RNFL defects may be caused by
69 A) in evaluation of inflammatory activity in Behcet's retinal vasculitis.
70  are increasingly used to treat aneurysms in Behcet patients.
71 gest that the robust HLA-B*51 association in Behcet's disease is explained by a variant located betwe
72                      Thrombosis is common in Behcet's Syndrome (BS), and there is a need for better b
73 umor necrosis factor, or both, is crucial in Behcet disease-associated relapsing uveitis and that int
74 ate immune response to microbial exposure in Behcet's disease susceptibility.
75 s (CMT), and microperimetry (MP) findings in Behcet uveitis (BU) patients who were in remission with
76 ltiple pathological pathways are involved in Behcet syndrome.
77                        Ocular involvement in Behcet's disease, if untreated, leads to blindness.
78  cause monogenic recessive diseases: MEFV in Behcet's disease and Henoch-Schonlein purpura, and A1AT
79 that other factors must also be operative in Behcet syndrome.
80 erial and venous thrombosis, particularly in Behcet syndrome, in which vascular inflammation has a cr
81 m and management of large vessel problems in Behcet disease, highlighting contributions over the past
82 anding knowledge on large vessel problems in Behcet's disease, highlighting recent contributions.
83 (GWAS) in vasculitis have been published, in Behcet's disease and Kawasaki disease; none of the genes
84 udy is the first systematic genome screen in Behcet's disease and provides evidence of linkage to sev
85 us to look at the pathologic changes seen in Behcet disease and sarcoidosis in more detail.
86 ave shown an increased rate of thrombosis in Behcet's disease, with a different clinical presentation
87 on in the management of venous thrombosis in Behcet's disease.
88  analysis of KIR3DL1/S1 allelic variation in Behcet disease and may provide insight into the pathogen
89  and mortality of large vessel vasculitis in Behcet disease are beginning to change.
90  and mortality of large vessel vasculitis in Behcet's disease are improving.
91        Other diagnosable conditions included Behcet disease, multifocal choroiditis, panuveitis, Croh
92          Main etiologies of uveitis included Behcet disease (27%), idiopathic juvenile arthritis (5.8
93              Main causes of uveitis included Behcet's disease (17.2%), birdshot chorioretinopathy (11
94 a number of inflammatory diseases, including Behcet's disease and age-related macular degeneration.
95 nd to maintain high suspicion for incomplete Behcet disease (BD) during early or atypical presentatio
96 analysis of 24,834 variants in 2 independent Behcet's disease cohorts from 2 ancestry groups.
97 r uveitis cases included diagnosis with JIA, Behcet's disease, bilateral uveitis, history of cataract
98 sorders including erythema nodosum leprosum, Behcet's syndrome, discoid lupus erythematosus, and Croh
99 ed with inflammatory bowel disease, leprosy, Behcet disease, and systemic juvenile idiopathic arthrit
100 n-invasive alternatives to FA for monitoring Behcet's retinal vasculitis.
101 he clinical and radiologic features of neuro-Behcet disease.
102  patients with quiescent, noninfectious, non-Behcet's uveitis (ENDURE study) were enrolled.
103  31 patients with active, noninfectious, non-Behcet's uveitis (INSURE study); and 125 patients with q
104 irst step toward the identification of novel Behcet's disease susceptibility genes.
105 oices of uveitis specialists treating ocular Behcet disease (P = .008).
106        We confirmed the known association of Behcet's disease with HLA-B*51 and identified a second,
107 ases of panuveitides, including 194 cases of Behcet disease with uveitis, were evaluated by machine l
108 nd small-vessel vasculitis characteristic of Behcet disease.
109            The neurological complications of Behcet's syndrome have not been characterized with clari
110                  An article on the course of Behcet's disease is reviewed as well as another article
111 r Behcet disease uveitis were a diagnosis of Behcet disease using the International Study Group for B
112 her characteristic or diagnostic features of Behcet's disease.
113 made in our understanding of the genetics of Behcet disease.
114                 Oral ulcers, the hallmark of Behcet's syndrome, can be resistant to conventional trea
115 ers, which are the cardinal manifestation of Behcet's syndrome.
116 ious uveitides (the ocular manifestations of Behcet's disease and sarcoidosis) based on multicolor fl
117 or the treatment of ocular manifestations of Behcet's disease.
118 icacy, the effect on other manifestations of Behcet's syndrome, or the risk of uncommon serious adver
119 ss in patients with a familial occurrence of Behcet's disease.
120 lpha) may play a role in the pathogenesis of Behcet's disease (BD).
121                      In the current study of Behcet disease (BD), nonsynonymous variants (NSVs) ident
122 correlated with disease activity in terms of Behcet's Disease Current Activity Form (BDCAF) (p < 0.00
123 as demonstrated efficacy in the treatment of Behcet's disease and other forms of posterior uveitis.
124                          The vasculopathy of Behcet's disease is distinctive among the vasculitides i
125 ic syndromes such as rheumatoid arthritis or Behcet's syndrome.
126  as multiple sclerosis, neurosarcoidosis, or Behcet's syndrome.
127 mic lupus erythematosus, Sjogren syndrome or Behcet disease and granulomatous diseases such as sarcoi
128 ochromic cyclitis (FHC), and herpes-viral or Behcet's uveitis were analyzed for IL-1beta, -2, -4, -5,
129 nfliximab and interferon alpha, particularly Behcet's disease-associated uveitis.
130                                    Pediatric Behcet's disease (PBD) is rarer than BD and can be a cha
131 mal set of 5 markers that accurately predict Behcet's disease and sarcoidosis.
132                       The disorder resembles Behcet's disease, which is typically considered a polyge
133 nosis of a rheumatologic disorder resembling Behcet disease.
134 genetically well defined, including Still's, Behcet's, and Schnitzler diseases.
135 a patient who had a vasculopathy fitting the Behcet's disease type, but who lacked the other characte
136 lear cells of individuals homozygous for the Behcet's disease-associated "G" allele.
137 litis cases and worse for uveitis related to Behcet disease, Vogt-Koyanagi-Harada disease, or sympath
138 etic effects that increase susceptibility to Behcet's disease in the UBAC2 locus.
139 ve emerged as a successful approach to treat Behcet's disease.
140                    We analyzed 1,900 Turkish Behcet's disease cases and 1,779 controls genotyped with
141                                      Vasculo-Behcet patients are at risk for multiple vessel-related
142 s (24 eyes) with RNFL defect associated with Behcet uveitis who returned for follow-up, there was a c
143 aging features of myelopathy associated with Behcet's disease (BD).
144 nous retinal detachment (RD) associated with Behcet's disease (BD).
145 gly, allotype 10, previously associated with Behcet's disease, is consistently a low-activity outlier
146 teristics of ocular disease in children with Behcet's disease is presented.
147 cribe a human cohort of 267 individuals with Behcet disease and 445 matched controls from a tertiary
148  with 311,459 SNPs in 1,215 individuals with Behcet's disease (cases) and 1,278 healthy controls from
149  genotypes in 1,209 Turkish individuals with Behcet's disease and 1,278 controls.
150                             Individuals with Behcet's disease suffer from episodic inflammation often
151 S: This study was including 32 patients with Behcet disease and 32 healthy sex and age-matched contro
152 ulitis occurs in a subgroup of patients with Behcet disease at high risk for disease-related morbidit
153  aware about blood pressure of patients with Behcet disease, especially with long term follow up.
154  color Doppler measurements in patients with Behcet disease.
155 e mechanisms, the prognoses of patients with Behcet syndrome, including those with eye disease, conti
156                      Sixty-two patients with Behcet uveitis (24%) had localized RNFL defect(s) withou
157 ed the clinical photographs of patients with Behcet uveitis (n = 259), ocular toxoplasmosis (n = 120)
158 ty and CMT showed no change in patients with Behcet uveitis receiving maintenance therapy, MP could d
159 chemokines and its receptor in patients with Behcet's disease (BD) and their associations with diseas
160 atients (n = 52, F:M = 40:12), patients with Behcet's disease (BD, n = 40, F:M = 29:11) as another sy
161 und in the peripheral blood of patients with Behcet's disease during episodes of ocular inflammation.
162 ulitis occurs in a subgroup of patients with Behcet's disease who are at high risk for disease-relate
163 -controlled study in which 111 patients with Behcet's syndrome who had two or more oral ulcers were r
164                 A total of 118 patients with Behcet's uveitis (SHIELD study); 31 patients with active
165              A chart review of patients with Behcet-associated uveitis who were evaluated from Januar

 
Page Top